BMS starts laying off workers

The ax is starting to fall at Bristol-Myers Squibb. The company has started notifying employees that they'll soon be out of a job. Details on how many jobs will be cut and which areas will feel the most pain are expected next Wednesday during Bristol's conference call with analysts.

Laid-off workers will get severance, plus help finding new jobs. Many of them are probably already looking, considering the fact that CEO James Cornelius (photo) has been talking layoffs since July. The conference call will be webcast for the public, in case anyone wants to hear the news firsthand.

- see the release about the webcast from BMS
- read the Post-Standard report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.